SEARCH

SEARCH BY CITATION

References

  • 1
    Sperber EF, Haas KZ, Stanton PK, Moshe SL, Resistance of the immature hippocampus to seizure-induced synaptic reorganization. Dev Brain Res 1991;60:8893.
  • 2
    Priel MR, Ferreira Dos Santos N, Cavalheiro EA, Developmental aspects of the pilocarpine model of epilepsy. Epilepsy Res 1996;26:11521.
  • 3
    Holmes GL, Epilepsy in the developing brain: lessons from the laboratory and clinic. Epilepsia 1997;38:1230.
  • 4
    Hauser WA, Seizure disorders: the changes with age. Epilepsia 1992;33(suppl 4):S614.
  • 5
    Holmes GL, The long term effects of seizures on the developing brain: clinical and laboratory studies. Brain Dev 1991;13:393409.
  • 6
    Camfield PR, Recurrent seizures in the developing brain are not harmful. Epilepsia 1997;38:7357.
  • 7
    Thompson K, Holm AM, Schousboe A, Popper P, Micevych P, Wasterlain C., Hippocampal stimulation produces neuronal death in the immature brain. Neuroscience 1997;82:33748.
  • 8
    Wasterlain CG, Recurrent seizures in the developing brain are harmful. Epilepsia 1997;38:72834.
  • 9
    Sankar R, Shin DH, Liu H, Mazarati A, Pereira de Vasconcelos A., Wasterlain CG, Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J Neurosci 1998;18:838293.
  • 10
    Pereira de Vasconcelos A., El Hamdi E., Vert P, Nehlig A., An experimental model of generalized seizures for the measurement of local cerebral glucose utilization in the immature rat. II. Mapping of brain metabolism using the quantitative [14]2-deoxyglucose technique. Dev Brain Res 1992;69:24359.
  • 11
    Pereira de Vasconcelos A., Boyet S, Koziel V, Nehlig A., Effects of pentylenetetrazol-induced status epilepticus on local cerebral blood flow in the developing rat. J Cereb Blood Flow Metab 1995;15:27083.
  • 12
    André V, Pineau N, Motte JE, Marescaux C, Nehlig A., Mapping of neuronal networks underlying generalized seizures induced by increasing doses of pentylenetetrazol in the immature and adult rat: a c-Fos immunohistochemical study. Eur J Neurosci 1998;10:2094106.
  • 13
    Hussenet F, Boyet S, Nehlig A., Long-term metabolic effects of pentylenetetrazol-induced status epilepticus in the immature rat. Neuroscience 1995;67:45561.
  • 14
    Nehlig A, Pereira de Vasconcelos A., The model of pentylenetetrazol-induced status epilepticus in the immature rat: short- and long-term effects. Epilepsy Res 1996;26:93103.
  • 15
    Edelman GM, Gally JA, Nitric oxide: linking space and time in the brain. Proc Natl Acad Sci U S A 1992;89:116512.
  • 16
    Schuman EM, Madison DV, Nitric oxide and synaptic function. Annu Rev Neurosci 1994;17:15383.
  • 17
    Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA, Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 1994;14:17592.
  • 18
    Pereira de Vasconcelos A., Baldwin R, Wasterlain C., Nitric oxide mediates the increase in local cerebral blood flow during focal seizures. Proc Natl Acad Sci U S A 1995;92:31759.
  • 19
    Dawson VL, Nitric oxide: role in neurotoxicity. Clin Exp Pharmacol Physiol 1995;22:3058.
  • 20
    De Sarro G, Di Paola ED, De Sarro A, Vidal MJ, Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex. Fundam Clin Pharmacol 1991;5:50311.
  • 21
    Mollace V, Bagetta G, Nistico G., Evidence that l-arginine possesses proconvulsant effects mediated through nitric oxide. Neuroreport 1991;2:26972.
  • 22
    Proctor MR, Fornai F, Afhar JKB, Gale K., The role of nitric oxide in focally-evoked limbic seizures. Neuroscience 1997;76:12316.
  • 23
    Rondouin G, Lerner-Natoli M, Manzoni O, Lafon-Cazal M, Bockaert J., A nitric oxide (NO) synthase inhibitor accelerates amygdala kindling. Neuroreport 1992;3:8058.
  • 24
    Buisson A, Lakhmeche N, Verrechia C, Plotkine M, Boulu RG, Nitric oxide: an endogenous anticonvulsant substance. Neuroreport 1993;4:4446.
  • 25
    Marangoz C, Ayyildiz M, Agar E., Evidence that sodium nitroprus-side possesses anticonvulsant effects mediated through nitric oxide. Neuroreport 1994;5:24546.
  • 26
    Babbedge RC, Bland-Ward PA, Hart SL, Moore PK, Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol 1993;110:2258.
  • 27
    Moore PK, Wallace P, Gaffen Z, Hart SL, Babbedge RC, Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol 1993;110:21924.
  • 28
    El Hamdi G., Pereira de Vasconcelos A., Vert P, Nehlig A., An experimental model of generalized seizures for the measurement of local cerebral glucose utilization in the immature rat. I. Behavioral characterization and determination of lumped constant. Dev Brain Res 1992;69:23342.
  • 29
    Rigaud-Monnet AS, Pinard E, Borredon J, Seylaz J., Blockade of nitric oxide synthesis inhibits hippocampal hyperemia in kainic acid-induced seizures. J Cereb Blood Flow Metab 1994;14:58190.
  • 30
    Van Leeuwen R, De Vries R, Dzolijc MR, 7-Nitro indazole, an inhibitor of neuronal nitric oxide synthase, attenuates pilocarpine-induced seizures. Eur J Pharmacol 1995;287:2113.
  • 31
    Kirkby RD, Forbes RA, Subramaniam S., Modification of kainate-induced behavioral and electrographic seizures following inhibition of nitric oxide in mice. Epilepsy Res 1996;24:7990.
  • 32
    Kirkby RD, Carroll DM, Grossman AB, Subramaniam S., Factors determining proconvulsant and anticonvulsant effects of inhibitors of nitric oxide synthase in rodents. Epilepsy Res 1996;24:91100.
  • 33
    Montccot C, Rondi-Reig L, Springhetti V, Seylaz J, Pinard E., Inhibition of neuronal (type 1) nitric oxide synthase prevents hyperemia and hippocampal lesions resulting from kainate-induced seizures. Neuroscience 1998;84:791800.
  • 34
    MacKenzie GM, Rose S, Bland-Ward PA, Moore PK, Jenner P, Marsden CD, Time course of inhibition of brain nitric oxide synthase by 7 nitroindazole. Neuroreport 1994;5:19936.
  • 35
    Bredt DS, Snyder SH, Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci U S A 1989;86:90303.
  • 36
    Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:24854.
  • 37
    Pineau N, Charriaut-Marlangue C, Motte J, Nehlig A., Pentylenetetrazol seizures induce cell suffering but not death in the immature rat brain. Dev Brain Res 1999;112:13944.
  • 38
    Pereira de Vasconcelos, A, Marescaux C, Nehlig A., Age-dependent regulation of seizure activity by nitric oxide in the developing rat. Dev Brain Res 1998;107:3159.
  • 39
    Starr MS, Starr BS, Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor l-NAME. Pharmacol Biochem Behav 1993;45:31225.
  • 40
    Penix LP, Davis W, Subramaniam S., Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res 1994;18:17784.
  • 41
    Osonoe K, Mori N, Suzuki K, Osonoe M., Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res 1994;663:33840.
  • 42
    Hara S, Kuriiwa F, Iwata N, Mukai T, Kano S, Endo T., Distinct effects of N-nitro-L-arginine on seizures induced by several drugs in mice. Pharmacol Biochem Behav 1996;53:6737.
  • 43
    Maggio R, Fumagalli F, Donati E, et al. Inhibition of nitric oxide synthase dramatically potentiates seizures induced by kainic acid and pilocarpine in rats. Brain Res 1995;679:1847.
  • 44
    Lefauconnier JM, Blood-brain amino acid transport during development. In: HuetherG, ed. Amino acid availability and brain function in health and disease. Berlin : Springer-Verlag, 1988:4039.
  • 45
    Leninger AL, Nelson DL, Michael MC, Principles of Biochemistry. 2nd ed. New York : Worth, 1993:69132.
  • 46
    Sun Y, Deibler GE, Jehle J, et al. Rates of local cerebral protein synthesis in the rat during normal postnatal development. Am J Physiol 1995;268:R54961.
  • 47
    Borowicz KK, Starownik R, Kleinrok Z, Czuczwar SJ, The influence of l-NG-nitroarginine methyl ester, an inhibitor of nitrie oxide synthase, upon the anticonvulsive activity of conventional antiepileptic drugs against maximal eleetroshock in mice. J Neural Transm 1998;105:112.
  • 48
    Rundfeldt C, Koch R, Richter A, Mevissen M, Gerecke U, Löscher W., Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. Eur J Pharmacol 1995;274:7381.
  • 49
    Sperber EF, Stanton PK, Ackermann RF, Moshe SL, Developmental differences in the neurobiology of epileptic brain damage. Epilepsy Res 1992;26:93103.
  • 50
    Browning RA, Anatomy of generalized convulsive seizures. In: MalafosseA, GentonP, HirschE, MarescauxC, BroglinD, BernasconiR, eds. Idiopathic generalized epilepsies: clinical, experimental and genetic aspects. London : John Libbey, 1994:399414.
  • 51
    Nehlig A, Pereira de Vasconcelos A., Boyet S., Quantitative auto-radiographic measurement of local cerebral glucose utilization in freely moving rats during postnatal development. J Neurosci 1988;8:232133.